Summary & Overview
CPT 67971: Full-Thickness Eyelid Reconstruction with Flap
CPT code 67971 represents full-thickness reconstruction of up to two thirds of an eyelid using a flap transferred from the opposing eyelid. This surgical procedure addresses significant eyelid defects that affect ocular protection and cosmetic appearance. Nationally, accurate coding for 67971 matters for appropriate surgical reimbursement, quality measurement in oculoplastic care, and ensuring continuity of staged reconstructions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns and authorization considerations, typical sites of service and clinical context for use of the code, and common billing practices associated with staged or multi-session reconstructions. The publication summarizes benchmarks and policy developments relevant to reconstructive eyelid surgery and highlights clinical scenarios where 67971 is typically used, such as post-oncologic resection or traumatic eyelid loss.
The report provides practical information for coding, billing staff, and policy analysts: how the code is described clinically, where the procedure is typically performed, and which payers commonly manage claims for this service. Data not available in the input will be noted as such in the detailed sections.
Billing Code Overview
CPT code 67971 describes reconstruction of up to two thirds of the surface area of an eyelid, full-thickness through the eyelid tissue, using a transferred tissue flap from the opposing eyelid. The procedure may be performed in stages and is intended to restore eyelid form and function after trauma, tumor resection, or congenital defect.
-
Service type: Surgical eyelid reconstruction using a flap (full-thickness eyelid repair)
-
Typical site of service: Ambulatory surgical center or hospital operating room
Clinical & Coding Specifications
Clinical Context
A 68-year-old male presents with a full-thickness defect of the lower eyelid involving approximately half of the eyelid surface after wide local excision of a basal cell carcinoma. The defect extends through anterior and posterior lamellae with retraction risk and exposure keratopathy. The oculoplastic surgeon performs a tarsoconjunctival flap (advancement or eyelid-sharing flap) transferred from the opposing upper eyelid to reconstruct up to two thirds of the lower eyelid, restoring eyelid margin continuity and protecting the ocular surface. The initial stage includes flap design, mobilization, and inset under local or monitored anesthesia care with planned division of the flap in a subsequent procedure if required.
Preoperative workflow includes oncologic clearance and imaging as indicated, informed consent documenting reconstructive plan and potential staged approach, preoperative photography, and coordination of anesthesia. Intraoperative workflow includes marking, administration of local anesthetic with epinephrine, hemostasis, full-thickness excision margins confirmation, flap harvest from the donor eyelid, layered closure, and documentation of laterality and any staged plan. Postoperative care includes topical antibiotics, eyelid shields, instructions to avoid Valsalva and eye rubbing, follow-up for flap viability assessment, and scheduling of stage-two division if performed. Billing typically reflects a reconstructive procedure of full-thickness eyelid involving tissue transfer and may include separate coding for staged procedures if the division is distinct and meets coding rules.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|